© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Truist Financial analyst Richard Newitter maintained a Buy rating on Penumbra (PEN – Research Report) yesterday and set a price target of ...